Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Tyra Biosciences, Inc. (NASDAQ: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision oncology therapeutics. The company's proprietary SNÃ…P platform enables the rapid and precise discovery of highly selective and potent small molecule drug candidates that target novel and validated oncogene driver mutations. Tyra's lead programs are designed to address acquired resistance to current therapies and improve outcomes for cancer patients.
The headquarters serves as the central hub for research and development, clinical operations, corporate administration, and strategic decision-making for the company.
Likely features modern laboratory facilities for drug discovery and development, and collaborative office spaces designed to foster innovation.
The work culture is expected to be science-driven, innovative, and collaborative, focusing on teamwork and a shared mission to advance cancer therapies. Emphasis on rigor, patient-centricity, and cutting-edge research.
The Carlsbad headquarters places Tyra Biosciences within a vibrant ecosystem of biotech companies, research institutions, and talent, facilitating collaborations and access to resources crucial for its R&D efforts.
Tyra Biosciences is primarily focused on its operations within the United States, particularly its research, development, and clinical trial activities. While its therapeutic candidates, if successful, would have a global impact, its physical operational presence is currently centered in the US. Collaborations and clinical trials may extend internationally as programs advance.
2330 Faraday Ave, Suite G
Carlsbad
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Tyra Biosciences' leadership includes:
Tyra Biosciences has been backed by several prominent investors over the years, including:
Tyra Biosciences has seen some key executive appointments in the past year, strengthening its leadership in development and finance.
Discover the tools Tyra Biosciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Tyra Biosciences likely uses common corporate email formats. The most probable formats are based on first name, last name, and initials.
[first_initial][last]@tyra.bio or [first].[last]@tyra.bio
Format
jdoe@tyra.bio or jane.doe@tyra.bio
Example
85%
Success rate
GlobeNewswire • May 22, 2024
Tyra Biosciences announced its participation in the Jefferies Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference in June 2024....more
GlobeNewswire • May 9, 2024
Tyra Biosciences reported its financial results for the first quarter ended March 31, 2024, and provided corporate updates, including progress on its TYRA-300 and TYRA-200 programs....more
GlobeNewswire • March 12, 2024
Tyra Biosciences announced the appointment of Alan Fuhrman as its new Chief Financial Officer, effective March 11, 2024....more
GlobeNewswire • February 15, 2024
Tyra Biosciences announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for TYRA-200, enabling the initiation of a Phase 1 clinical trial for patients with activating FGFR2 gene alterations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Tyra Biosciences, are just a search away.